![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, July 2001, p. 847-849, Vol. 8, No. 4
Unité des Rickettsies, CNRS UPRES-A
6020, Faculté de Médecine, Université de la
Mediterranée, 13385 Marseille Cédex, France
Received 26 October 2000/Returned for modification 22 January
2001/Accepted 3 April 2001
Monoclonal antibodies (MAbs) which react with heat-resistant
proteins with molecular masses of 32 to 33 kDa of 14 different Bartonella species were produced. These antibodies did not
react with antigens of 26 diverse bacterial strains by
microimmunofluorescence assay except MAb B3D4, which reacted with
Chlamydia psittaci and Chlamydia trachomatis at
low titers. The identification of a common Bartonella
antigenic protein will make it possible to later produce a diagnostic
antigen by cloning and expressing it in Escherichia coli.
Moreover, these MAbs allow all Bartonella species to be identified to the genus level.
The genus Bartonella
currently comprises 14 species. Human infections due to
Bartonella species are widely considered emerging diseases,
although they also include long-recognized diseases such as
Carrión's disease, trench fever, and cat scratch disease (15, 17, 23). Newer clinical manifestations, such as
bacillary angiomatosis, peliosis hepatis, chronic lymphadenopathy, and
endocarditis, which are sometimes due to uncommonly encountered species
such as Bartonella elizabethae, Bartonella vinsonii subsp.
berkhoffii, or Bartonella vinsonii subsp.
arupensis, have been recently identified (1, 23, 25,
28, 32). Serologic diagnosis of Bartonella spp. is
mostly based on microimmunofluorescence (MIF) serology that detects
antibodies to B. quintana and B. henselae only
(21, 23). A serologic test that detects antibodies against
all species is not available. Such a test needs to detect an epitope
common to, but also specific to, all Bartonella spp. A
monoclonal antibody (MAb) that can recognize this epitope would be the
first step towards detecting this antigen after cloning and expressing
the Bartonella genome in Escherichia coli in
order to produce it for use in an enzyme-linked immunosorbent assay.
Bartonella spp. may be isolated from clinical samples by
using cell culture systems with endothelial cells or blood- or
hemin-containing axenic media (21, 29). When isolated,
identification of Bartonella is mostly based on molecular
methods. The availability of a MAb that could screen
Bartonella at the genus level would avoid the use of
expensive and time-consuming molecular procedures on
non-Bartonella bacteria. We thus decided to produce and
characterize Bartonella genus-specific MAbs.
The sources of Bartonella strains used to screen hybridomas
and test the specificity of MAbs are presented in Table
1. Bartonella strains were
harvested and suspended in deionized water for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or in
phosphate-buffered saline (PBS) for the MIF assay after 5 to 7 days of
culture on blood agar plates. The procedure for the production of MAbs
has been detailed elsewhere (12, 22). Briefly,
6-week-old female BALB/c mice were inoculated with B. henselae Houston-1 suspended in 0.5 ml of PBS. The supernatants of
the hybridomas were screened for antibodies to B. henselae by MIF. Representative hybridomas were subcloned twice by limiting dilution. Isotypes of MAbs were determined with an Immuno Type mouse
monoclonal antibody isotyping kit with antisera to mouse immunoglobulin
M (IgM), IgA, IgG1, IgG2a, IgG2b, and IgG3 (Sigma). Ascitic fluids were
produced by injecting about 3 × 106 cells of
hybridoma (B2D3 and B3D4) suspended in 0.5 ml of PBS into the mice 1 week after an intraperitoneal injection of 0.5 ml of pristane
(2,6,10,14-tetramethylpentadecane; Sigma). The MIF assay
(26) was used to screen hybridoma clones and to determine the specificity of the MAbs. Blind testing of 45 bacteria by MIF with
MAbs B2D3 and B3D4 was carried out on 19 Bartonella strains, 3 Chlamydia strains, and 23 bacterial strains isolated in
our laboratory from clinical samples (Table 1). Sera from immunized mice were used as positive controls, and sera from healthy mice were
used as negative controls. SDS-PAGE and Western blotting were performed
according to a modification of the method described by Laemmli
(19, 22). Five human body lice from a laboratory colony
were infected with a B. quintana strain by feeding on a bacteremic rabbit previously infected intravenously by 108
B. quintana cells. B. quintana bacteremia at the
time the lice were fed was assessed by blood culture as previously
described for cats (3). After being crushed and smeared
onto microscope slides the lice were tested for Bartonella
by MIF as described above with ascitic fluid of hybridoma B2D3 diluted
1:1,000.
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.4.847-849.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Production of Bartonella
Genus-Specific Monoclonal Antibodies
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
TABLE 1.
Reactivity of MAbs with Bartonella antigens
SDS-PAGE analysis of Bartonella antigens demonstrated
distinct profiles of Bartonella species. Depending on
species, 12 to 35 bands were observed. Proteins of 85, 71, 54, 44 to
47, 40, 36, 32 to 33, 30, and 18 to 19 kDa were common to all
Bartonella strains studied (Fig.
1a). Both MAbs reacted with all tested
Bartonella species. The immunofluorescence assay titers of
MAbs with different Bartonella bacteria showed obvious
differences. Titers from the homologous strain Houston-1 were the
highest. The isotypes of B2D3 and B3D4 were identified as subclass
IgG1. MAbs B2D3 and B3D4 showed reactivity with 32- or 33-kDa protein
bands (Fig. 1b). The MAbs were directed against heat-resistant proteins
because digestion with proteinase K completely destroyed the antigen's reactivities and heat treatment at 100°C for 10 min did not. The ascitic fluid from hybridomas B2D3 and B3D4 reacted with all of the
Bartonella strains tested, but it did not react with the 23 other bacteria tested. Cross-reactivity was observed with
Chlamydia psittaci and Chlamydia trachomatis.
Nevertheless, the immunofluorescence assay titers of MAbs to
Chlamydia spp. were much lower (Table 1).
Bartonella spp. were demonstrated in four of the five
infected lice by MIF with MAbs B2D3 and B3D4.
|
The clinical manifestations of infections due to Bartonella, Coxiella, and Chlamydia can often be confused, especially in cases of infectious endocarditis. However, differential diagnosis of the diseases is important because their treatments are different. As Chlamydia spp. and Coxiella burnetii are strictly intracellular bacteria and Bartonella spp. are fastidious slowly growing organisms, they are difficult to isolate. Therefore, diagnosis of these infections continues to rely mainly on serology in spite of the serological cross-reactions among members of these genera that have been described (11, 20, 24). Moreover, because recently described species such as B. elizabethae, B. vinsonii subsp. berkhoffii, B. vinsonii subsp. arupensis, and B. clarridgeiae may be encountered in humans, a specific serologic test that recognizes all Bartonella infections is needed. In our work, we have obtained, as a first step, MAbs that recognize a protein antigen common to all Bartonella species. After cloning the Bartonella sp. genome in E. coli in order to obtain an expression bank, these MAbs could be used for screening products of clones in order to obtain a protein antigen common to all Bartonella spp. that could be used in an enzyme-linked immunosorbent assay for the detection of antibodies to all Bartonella spp. The anti-Bartonella genus-specific MAbs obtained in this study are highly specific, as they did not cross-react with 26 other bacterial species, except that MAb B3D4 cross-reacted at low titers with C. trachomatis and C. psittaci. Interestingly, none of the MAbs obtained reacted with Chlamydia pneumoniae or Coxiella burnetii, in spite of the cross-reactivity of these two genera and Bartonella spp. which has been previously described (11, 20, 24). Serological cross-reactivity between B. bacilliformis and C. psittaci antigens has been demonstrated previously (16). It was associated with a cross-reacting lipopolysaccharide antigen. Cross-reactivity between B. quintana, C. psittaci, and C. pneumoniae was later demonstrated in patients with B. quintana endocarditis (8). The serological cross-reactivity of Bartonella sp. and Chlamydia sp. antigens in the sera of patients infected by a member of these genera was also demonstrated to be due to cross-reacting protein antigens with molecular masses ranging from 30 to 90 kDa (24). Thus, our MAb B3D4 could also be used to investigate cross-reacting epitopes between Bartonella spp. and Chlamydia spp.
In conclusion, our Bartonella genus-specific MAbs recognized specifically all the tested species of Bartonella, and they successfully detected B. quintana in body lice. Thus, our MAbs may provide a tool to identify, at the genus level, isolated bacteria for which presumptive identification is compatible with Bartonella spp. or to detect such bacteria within arthropods, avoiding the use of molecular techniques for screening (4, 21).
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to R. Birtles for reviewing the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité des Rickettsies, Faculté de Médecine, 27 Blvd. Jean Moulin, 13385 Marseille Cédex 5, France. Phone: (33) 4 91 32 43 75. Fax: (33) 4 91 83 03 90. E-mail: Didier.Raoult{at}medecine.univ-mrs.fr.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Anderson, B. E., and M. A. Neuman. 1997. Bartonella spp. as emerging human pathogens. Clin. Microbiol. Rev. 10:203-219[Abstract]. |
| 2. |
Birtles, R. J.,
T. G. Harrison,
N. A. Saunders, and D. H. Molyneux.
1995.
Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp. nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov.
Int. J. Syst. Bacteriol.
45:1-8 |
| 3. | Brenner, S. A., J. A. Rooney, P. Manzewitsch, and R. L. Regnery. 1997. Isolation of Bartonella (Rochalimaea) henselae: effects of methods of blood collection and handling. J. Clin. Microbiol. 35:544-547[Abstract]. |
| 4. |
Brouqui, P.,
B. La Scola,
V. Roux, and D. Raoult.
1999.
Chronic Bartonella quintana bacteremia in homeless patients.
N. Engl. J. Med.
340:184-189 |
| 5. |
Daly, J. S.,
M. G. Worthington,
D. J. Brenner,
C. W. Moss,
D. G. Hollis,
R. S. Weyant,
A. G. Steigerwalt,
R. E. Weaver,
M. I. Daneshvar, and S. P. O'Connor.
1993.
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.
J. Clin. Microbiol.
31:872-881 |
| 6. |
Dolan, M. J.,
M. T. Wong,
R. L. Regnery,
J. H. Jorgensen,
M. Garcia,
J. Peters, and D. Drehner.
1993.
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease.
Ann. Intern. Med.
118:331-336 |
| 7. | Drancourt, M., R. Birtles, G. Chaumentin, F. Vandenesch, J. Etienne, and D. Raoult. 1996. New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet 347:441-443[CrossRef][Medline]. |
| 8. |
Drancourt, M.,
J. L. Mainardi,
P. Brouqui,
F. Vandenesch,
A. Carta,
F. Lehnert,
J. Etienne,
F. Goldstein,
J. Acar, and D. Raoult.
1995.
Bartonella (Rochalimaea) quintana endocarditis in three homeless men.
N. Engl. J. Med.
332:419-423 |
| 9. | Drancourt, M., V. Moal, P. Brunet, B. Dussol, Y. Berland, and D. Raoult. 1996. Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient. J. Clin. Microbiol. 34:1158-1160[Abstract]. |
| 10. |
Droz, S.,
B. Chi,
E. Horn,
A. G. Steigerwalt,
A. M. Whitney, and D. J. Brenner.
1999.
Bartonella koehlerae sp. nov., isolated from cats.
J. Clin. Microbiol.
37:1117-1122 |
| 11. | Dupon, M., A.-M. Savin de Larclause, P. Brouqui, M. Drancourt, D. Raoult, A. De Mascarel, and J. Y. Lacut. 1996. Evaluation of serological response to Bartonella henselae, Bartonella quintana and Afipia felis antigens in 64 patients with suspected cat-scratch disease. Scand. J. Infect. Dis. 28:361-366[Medline]. |
| 12. | Harlow, E., and D. Lane. 1988. Monoclonal antibodies, growing hybridomas, p. 139-282. In E. Harlow, and D. Lane (ed.), Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 13. |
Heller, R.,
M. Kubina,
P. Mariet,
P. Riegel,
G. Delacour,
C. Dehio,
F. Lamarque,
R. Kasten,
H. J. Boulouis,
H. Monteil,
B. Chomel, and Y. Piemont.
1999.
Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits.
Int. J. Syst. Bacteriol.
49:283-288 |
| 14. |
Heller, R.,
P. Riegel,
Y. Hansmann,
G. Delacour,
D. Bermond,
C. Dehio,
F. Lamarque,
H. Monteil,
B. Chomel, and Y. Piémont.
1998.
Bartonella tribocorum sp. nov., a new Bartonella species isolated from the blood of wild rats.
Int. J. Syst. Bacteriol.
48:1333-1339 |
| 15. | Jerris, R. C., and R. L. Regnery. 1996. Will the real agent of cat-scratch disease please stand up? Annu. Rev. Microbiol. 50:707-725[CrossRef][Medline]. |
| 16. | Knobloch, J., R. Bialek, G. Müller, and P. Asmus. 1988. Common surface epitope of Bartonella bacilliformis and Chlamydia psittaci. Am. J. Trop. Med. Hyg. 39:427-433. |
| 17. | Kordick, D. L., E. J. Hilyard, T. L. Hadfield, K. H. Wilson, A. G. Steigerwalt, D. J. Brenner, and E. B. Breitschwerdt. 1997. Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease). J. Clin. Microbiol. 35:1813-1818[Abstract]. |
| 18. |
Kordick, D. L.,
B. Swaminathan,
C. E. Greene,
K. H. Wilson,
A. M. Whitney,
S. O'Connor,
D. G. Hollis,
G. M. Matar,
A. G. Steigerwalt,
G. B. Malcolm,
P. S. Hayes,
T. L. Hadfield,
E. B. Breitschwerdt, and D. J. Brenner.
1996.
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii.
Int. J. Syst. Bacteriol.
46:704-709 |
| 19. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 20. | La Scola, B., and D. Raoult. 1996. Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J. Clin. Microbiol. 34:2270-2274[Abstract]. |
| 21. |
La Scola, B., and D. Raoult.
1999.
Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998).
J. Clin. Microbiol.
37:1899-1905 |
| 22. |
Liang, Z., and D. Raoult.
2000.
Species-specific monoclonal antibodies for rapid identification of Bartonella quintana.
Clin. Diagn. Lab. Immunol.
7:21-24 |
| 23. | Maurin, M., R. J. Birtles, and D. Raoult. 1997. Current knowledge of Bartonella species. Eur. J. Clin. Microbiol. Infect. Dis. 16:487-506[CrossRef][Medline]. |
| 24. | Maurin, M., F. Eb, J. Etienne, and D. Raoult. 1997. Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J. Clin. Microbiol. 35:2283-2287[Abstract]. |
| 25. | Maurin, M., and D. Raoult. 1996. Bartonella (Rochalimaea) quintana infections. Clin. Microbiol. Rev. 9:273-292[Abstract]. |
| 26. |
Philip, R. N.,
E. A. Casper,
W. Burgdorfer,
R. K. Gerloff,
L. E. Hughes, and E. J. Bell.
1978.
Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence.
J. Immunol.
121:1961-1968 |
| 27. |
Regnery, R. L.,
B. E. Anderson,
J. E. Clarridge III,
M. C. Rodriguez-Barradas,
D. C. Jones, and J. H. Carr.
1992.
Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient.
J. Clin. Microbiol.
30:265-274 |
| 28. |
Roux, V.,
S. J. Eykyn,
S. Wyllie, and D. Raoult.
2000.
Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human.
J. Clin. Microbiol.
38:1698-1700 |
| 29. |
Schwartzman, W. A.,
C. A. Nesbit, and E. J. Baron.
1993.
Development and evaluation of a blood-free medium for determining growth curves and optimizing growth of Rochalimaea henselae.
J. Clin. Microbiol.
31:1882-1885 |
| 30. | Varela, G., J. W. Vinson, and C. Molina-Pasquel. 1969. Trench fever. II. Propagation of Rickettsia quintana on cell-free medium from the blood of two patients. Am. J. Trop. Med. Hyg. 18:708-712. |
| 31. |
Weiss, E.,
G. A. Dasch,
D. R. Woodman, and J. C. Williams.
1978.
Vole agent identified as a strain of the trench fever rickettsia, Rochalimaea quintana.
Infect. Immun.
19:1013-1020 |
| 32. |
Welch, D. F.,
K. C. Carroll,
E. K. Hofmeister,
D. H. Persing,
D. A. Robison,
A. G. Steigerwalt, and D. J. Brenner.
1999.
Isolation of a new subspecies, Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice.
J. Clin. Microbiol.
37:2598-2601 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |
